Spain Authorizes The First Trials On Phase 3 Of Johnson and Johnson's Vaccine Against Covid-19

MADRID, SPAIN – NOVEMBER 19: A sign for Johnson & Johnson is seen outside the Johnson & Johnson headquarters on November 19, 2020 in Madrid, Spain. The Spanish Agency for Medicines and Health Products (AEMPS) has authorized the first phase 3 clinical trial on November 18, 2020 for the COVID-19 vaccine from the company Janssen, belonging to the American multinational Johnson & Johnson. Trials of this vaccine had to be stopped due to "unexplained illness" in one participant. The tests were resumed eleven days later, after verifying that the event was not related to the administration of the drug. (Footage by David Benito/Getty Images)